Profile data is unavailable for this security.
About the company
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
- Revenue in USD (TTM)12.67bn
- Net income in USD407.00m
- Incorporated1992
- Employees25.00k
- LocationHenry Schein Inc135 Duryea RdMELVILLE 11747United StatesUSA
- Phone+1 (631) 843-5500
- Fax+1 (302) 636-5454
- Websitehttps://www.henryschein.com/
More ▼
Mergers & acquisitions
| Acquired company | HSIC:NSQ since announced | Transaction value |
|---|---|---|
| Acentus LLC | -7.67% | -- |
| ABC Dental AG | -4.44% | -- |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 3.01bn | 149.53m | 5.02bn | 14.10k | 35.77 | 1.24 | 11.80 | 1.67 | 3.18 | 3.17 | 64.50 | 91.67 | 0.4112 | 2.10 | 6.59 | 213,485.40 | 2.04 | 4.58 | 2.23 | 5.01 | 55.68 | 54.77 | 4.97 | 11.38 | 1.32 | 7.59 | 0.3178 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Lantheus Holdings Inc | 1.54bn | 254.32m | 5.09bn | 808.00 | 20.89 | 4.37 | 16.06 | 3.31 | 3.52 | 3.52 | 21.62 | 16.84 | 0.7908 | 7.96 | 4.48 | 1,901,855.00 | 13.09 | 9.87 | 14.95 | 11.33 | 64.04 | 60.44 | 16.55 | 12.86 | 5.46 | -- | 0.3275 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| Glaukos Corp | 404.52m | -123.68m | 5.66bn | 995.00 | -- | 7.35 | -- | 13.98 | -2.31 | -2.31 | 7.42 | 13.46 | 0.4259 | 1.79 | 6.85 | 406,555.80 | -13.02 | -11.24 | -14.06 | -12.04 | 75.75 | 73.54 | -30.57 | -36.68 | 5.62 | -- | 0.083 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Guardant Health Inc | 774.00m | -416.55m | 5.86bn | 2.00k | -- | -- | -- | 7.57 | -3.38 | -3.38 | 6.28 | -2.03 | 0.5077 | 4.27 | 7.74 | 387,191.60 | -27.33 | -24.20 | -32.00 | -26.83 | 61.34 | 63.23 | -53.82 | -91.24 | 3.76 | -38.58 | 1.29 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Bruker Corp | 3.45bn | 79.60m | 6.39bn | 11.40k | 80.34 | 3.52 | 22.87 | 1.86 | 0.5252 | 0.5252 | 22.83 | 11.99 | 0.6602 | 1.56 | 5.74 | 302,395.60 | 1.53 | 6.80 | 2.04 | 9.20 | 49.28 | 50.00 | 2.32 | 9.66 | 0.7164 | 13.77 | 0.5331 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Bio Rad Laboratories Inc | 2.54bn | -2.16bn | 6.83bn | 7.70k | -- | 1.03 | -- | 2.69 | -76.20 | -76.20 | 90.48 | 241.72 | 0.2296 | 1.50 | 5.84 | 330,010.40 | -19.55 | 3.00 | -20.45 | 3.15 | 53.68 | 55.37 | -85.17 | 14.51 | 4.43 | 0.1031 | 0.1525 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Stevanato Group SpA | 1.30bn | 145.50m | 6.96bn | 5.52k | 47.81 | 4.24 | 29.63 | 5.33 | 0.5332 | 0.5332 | 4.78 | 6.02 | 0.4958 | 2.94 | 2.72 | 236,192.30 | 5.53 | 8.02 | 7.00 | 10.94 | 28.71 | 31.01 | 11.16 | 13.24 | 1.26 | -- | 0.2174 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Repligen Corp | 650.43m | -22.98m | 6.97bn | 1.78k | -- | 3.51 | 99.59 | 10.71 | -0.4124 | -0.4124 | 11.57 | 35.34 | 0.2282 | 1.81 | 4.94 | 365,820.60 | -0.8061 | 3.28 | -0.8557 | 3.70 | 51.15 | 54.24 | -3.53 | 12.37 | 5.79 | -- | 0.2106 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
| Globus Medical Inc | 2.51bn | 185.56m | 7.79bn | 5.30k | 43.05 | 1.91 | 17.28 | 3.10 | 1.34 | 1.34 | 18.11 | 30.20 | 0.5201 | 1.05 | 4.70 | 473,737.80 | 3.84 | 4.70 | 4.37 | 5.18 | 69.00 | 70.59 | 7.39 | 9.73 | 2.72 | 20.57 | 0.0001 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Masimo Corp | 1.97bn | -276.60m | 8.59bn | 3.60k | -- | 9.07 | -- | 4.35 | -5.17 | -9.21 | 36.51 | 17.46 | 0.7517 | 2.42 | 6.30 | 548,222.30 | -10.54 | 3.29 | -13.17 | 3.99 | 50.50 | 53.94 | -14.02 | 4.56 | 1.62 | 2.12 | 0.4075 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
| Henry Schein Inc | 12.67bn | 407.00m | 8.69bn | 25.00k | 21.60 | 2.57 | 12.46 | 0.6858 | 3.22 | 3.22 | 100.12 | 27.08 | 1.23 | 4.91 | 7.86 | 506,760.00 | 3.88 | 5.43 | 6.38 | 9.19 | 31.60 | 30.23 | 3.16 | 3.98 | 0.7525 | 6.94 | 0.3799 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Caris Life Sciences Inc | 452.50m | -371.16m | 8.70bn | -- | -- | -- | -- | 19.22 | -1.34 | -1.34 | 1.63 | -1.27 | -- | -- | -- | -- | -- | -- | -- | -- | 46.71 | -- | -60.43 | -- | 0.8285 | -4.42 | 16.39 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Penumbra Inc | 1.24bn | 42.23m | 8.91bn | 4.50k | 224.30 | 7.34 | 140.48 | 7.19 | 1.03 | 1.03 | 31.38 | 31.35 | 0.7816 | 1.02 | 6.89 | 275,577.80 | 2.66 | 1.42 | 2.95 | 1.58 | 66.37 | 63.21 | 3.41 | 1.96 | 3.68 | -- | 0.019 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Avantor Inc | 6.69bn | 715.60m | 9.06bn | 13.50k | 12.66 | 1.49 | 8.08 | 1.35 | 1.05 | 1.05 | 9.80 | 8.95 | 0.5329 | 5.69 | 6.01 | 495,200.00 | 5.70 | 3.94 | 6.62 | 4.48 | 33.56 | 33.76 | 10.70 | 6.87 | 0.7532 | 3.95 | 0.4024 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
| Revvity Inc | 2.77bn | 296.04m | 11.27bn | 11.00k | 39.47 | 1.49 | 15.79 | 4.07 | 2.42 | 2.35 | 22.70 | 63.96 | 0.2148 | 3.05 | 4.59 | 251,806.20 | 2.30 | 4.31 | 2.49 | 4.84 | 56.25 | 58.50 | 10.69 | 15.78 | 2.99 | 14.59 | 0.2932 | 6.52 | 0.162 | -0.9086 | 57.70 | 4.20 | 1.27 | 4.56 |
Data as of Jul 18 2025. Currency figures normalised to Henry Schein Inc's reporting currency: US Dollar USD
44.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 14.23m | 11.46% |
| Artisan Partners LPas of 31 Mar 2025 | 6.41m | 5.16% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 6.26m | 5.04% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2025 | 5.62m | 4.53% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 5.36m | 4.32% |
| American Century Investment Management, Inc.as of 31 Mar 2025 | 4.60m | 3.71% |
| Palestra Capital Management LLCas of 31 Mar 2025 | 4.00m | 3.22% |
| Geode Capital Management LLCas of 31 Mar 2025 | 3.22m | 2.60% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 2.80m | 2.26% |
| Southpoint Capital Advisors LPas of 31 Mar 2025 | 2.60m | 2.09% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
